SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is experiencing heightened volatility and intense community debate following a short-seller report questioning the company's scandium supply chain, which the firm has formally denied. Investors are closely monitoring the stock ahead of upcoming earnings, balancing skepticism over high valuations against bullish sentiment regarding Blooms role in providing off-grid power solutions for the rapidly expanding AI data center sector.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is trending as investors react to the company's aggressive expansion into AI infrastructure, specifically the full commercialization of its massive Beacon Point data center campus in Texas through a landmark 15-year lease. Community sentiment remains polarized, with some bulls highlighting the company's strong long-term revenue visibility and status as a top-tier data center play, while others express frustration over institutional selling and market volatility that often erodes recent gains.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense debate as investors weigh the company's aggressive debt-fueled AI infrastructure spending and credit rating concerns against its massive cloud service backlog. The community is sharply divided, with some betting on a long-term turnaround fueled by enterprise demand, while others caution that the current volatility and high capital expenditures signal further downside risks.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is drawing intense community focus as traders debate the disconnect between robust aircraft delivery numbers, key government contract wins, and the stock's persistent price volatility. Investors are actively discussing whether the company's long-term turnaround strategy and production ramp-up can overcome recent regulatory hurdles and institutional selling pressure ahead of upcoming earnings.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently trending as shareholders speculate on potential upcoming partnerships and the status of its proprietary COVID-Influenza Combination (CIC) vaccine ahead of the next earnings cycle. Community sentiment remains deeply divided, with some investors expressing frustration over management's lack of communication regarding pipeline assets, while others look to the strategic licensing of the Matrix-M adjuvant as a sign of long-term growth potential.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending following the FDA approval of its tumor-only xT CDx diagnostic platform, which significantly expands the company's competitive moat in precision oncology. While the community is actively debating the stock's long-term potential as a data-driven AI platform versus concerns over current profitability, retail investors are closely monitoring high short interest and institutional activity as catalysts for potential volatility.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending following the unveiling of "Thunder," an autonomous hybrid-electric VTOL platform developed in partnership with Anduril Industries for defense and commercial applications. The community is actively debating the company's progress on piloted transition flights and the potential impact of this new defense-focused collaboration on future revenue, while some investors express frustration over stock performance and persistent skepticism regarding timelines.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending as Tempus AI moves to acquire the company for approximately $1.5 billion, a strategic deal aimed at strengthening Tempus' oncology and precision medicine platform. While the acquisition provides a floor for the stock price, shareholders are actively debating whether the valuation represents a fair premium or a missed opportunity for a potential bidding war from other oncology leaders.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings is trending as retail investors engage in a heated, polarized debate over its volatile price action, with many discussing its struggle to maintain momentum compared to other fintech peers. The community is heavily focused on the stock's significant short interest, technical breakdown, and the high-stakes pressure building ahead of the next earnings release.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is seeing intense community discussion and high volume as investors monitor its Ibtrozi commercial launch and the promising Phase 3 development of its glioma candidate, safusidenib. While volatility persists, the community remains focused on the company's strong cash position, potential for future M&A, and the leadership of a CEO with a proven track record of biotech acquisitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Strongbridge Biopharmaâs primary focus has been to build its franchise around rare endocrine disorders, which includes product candidates for the treatment of endogenous Cushingâs syndrome and acromegaly, two rare diseases with a high unmet need for innovative treatment options. Given the well-identified and concentrated prescriber base addressing its target markets, the Company intends to use a small, focused sales force to market its products, if approved, in the United States, European Union and other key global markets. The Company intends to identify and in-license or acquire products or product candidates that would be complementary to its existing rare endocrine franchise or that would form the basis for new rare disease franchises.

Strongbridge Biopharma plc

Neutral Sentiment

Investment platforms / apps

Social media

Financial media 

Artificial Intelligence

Where do you usually get information about ETFs? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Where do you usually get information about ETFs? 
 
*Sponsored by Calamos and S&P Global

Feed

News

Sentiment

Fundamentals

Info

SBBPCortendo

Fundamentals

Latest SBBP News